IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $4,644,000 | +251.0% | 131,045 | +33.5% | 0.01% | +250.0% |
Q1 2020 | $1,323,000 | -43.6% | 98,125 | -11.5% | 0.00% | -33.3% |
Q4 2019 | $2,345,000 | +33.2% | 110,825 | -16.6% | 0.00% | 0.0% |
Q3 2019 | $1,761,000 | +0.9% | 132,812 | +5.6% | 0.00% | 0.0% |
Q2 2019 | $1,745,000 | -56.8% | 125,812 | -40.2% | 0.00% | -50.0% |
Q1 2019 | $4,038,000 | -7.0% | 210,218 | -30.9% | 0.01% | -25.0% |
Q4 2018 | $4,342,000 | -32.9% | 304,288 | -2.1% | 0.01% | -20.0% |
Q3 2018 | $6,474,000 | +27.2% | 310,788 | +44.5% | 0.01% | +25.0% |
Q2 2018 | $5,091,000 | +104.0% | 215,088 | +25.9% | 0.01% | +100.0% |
Q1 2018 | $2,495,000 | -2.7% | 170,800 | +7.7% | 0.00% | 0.0% |
Q4 2017 | $2,563,000 | +18.6% | 158,600 | +2.6% | 0.00% | +33.3% |
Q3 2017 | $2,161,000 | +62.7% | 154,600 | +2.8% | 0.00% | +50.0% |
Q2 2017 | $1,328,000 | +55.3% | 150,400 | +13.8% | 0.00% | +100.0% |
Q1 2017 | $855,000 | – | 132,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |